| abstract |
The present invention discloses novel compounds having HCV protease inhibitory activity and methods for preparing such compounds. In another embodiment, the present invention discloses pharmaceutical compositions comprising such compounds and methods for their use to treat HCV protease related disorders. The present invention, in its many embodiments, includes novel compounds as inhibitors of HCV protease, pharmaceutical compositions containing one or more of the compounds, methods of preparing formulations comprising one or more of such compounds, A method of treating or preventing HCV or alleviating one or more symptoms of hepatitis C using one or more of such compounds or one or more of such formulations, and one or more of such compounds Methods are provided for modulating the interaction of HCV polypeptides and HCV proteases using a plurality or one or more of such formulations. |